What’s shifting in obstructive hypertrophic cardiomyopathy (oHCM) care? In this short video, Dr. García-Pavía reviews recent findings on symptom relief, safety, and the future of oHCM treatment:

With new trial data emerging, the conversation around obicetrapib in lipid management is shifting. This highlights the need to revisit familiar pathways with fresh evidence. Explore where it may fit in evolving treatment strategies: #ClinicalTrials.

#DUPLEX confirms sparsentan’s potential in #FSGS. Patients had greater #proteinuria remission and more stable eGFR vs irbesartan, with consistent benefits across key timepoints. Hear more in this CME: . #Nephrology #Sparsentan

Less than 3 weeks to go! #WHAV returns on Sept. 20 in NYC. If you haven’t registered yet, now’s the time: #WHAV2025 #CME #MedTwitter #WomensHealth #MedEd.

The #DUPLEXTrial showed sparsentan reduced #proteinuria—even in genetic #FSGS subgroups—without added edema or toxicity. It also helped launch #PARASOL, advancing proteinuria as a potential surrogate endpoint. Hear more: . #Nephrology #CME.

How are treatment & research evolving in IgAN? Dr. Cheung previews our #IgAN2025 satellite symposium—built for healthcare providers—featuring case-based discussions on therapeutic targets, biomarkers, personalization, research updates & care standards.

Learn how the PARASOL initiative is addressing this challenge: #FSGS #Nephrology #Proteinuria #ClinicalTrials #CME.

Should #proteinuria be accepted as a surrogate endpoint in #FSGS clinical trials?. #Nephrology #ClinicalTrials.

RT @DoctorDietrich: Thank you to @ReachMD for the opportunity to discuss PD-L1 negative disease and long term results of CTLA/PD1 dual immu….

If you haven’t registered for #WHAV2025 yet, now’s the time!. NYC | Sept 20.View the full agenda and claim your spot: #WomensHealth #CME #OBGYN #Gynecology @OmniaEducation.

We’re 1 month away from #WHAV2025! What topic are you most excited about?.

Gain insights on interdisciplinary #ThyroidEyeDisease care in this interactive live symposium featuring real-world cases and expert guidance. Register for the in-person event: Sign up for lives broadcast: #Endocrinology

Explore the evolving landscape of #IgAN at our live satellite symposium! Join us for case-based insights into cutting-edge biomarkers, evolving guidelines, and emerging treatment strategies. Register now: . #LiveEvent #MedEd #CME #Nephrology

Can proteinuria become a validated surrogate in #FSGS? . The PARASOL initiative links 2-year levels to reduced kidney failure risk—supporting faster approvals and future trials. Discover more: . #Nephrology #CME #Proteinuria #ClinicalTrials

Why does Barbara Dehn keep coming back to #WHAV? . Watch her message – and see why you should join her in NYC on Sept. 20. Register: #WHAV2025 #WomensHealth #OBGYN

The #DUPLEXTrial enrolled a real-world #FSGS population and showed encouraging safety data. Dr. Trachtman shares how sparsentan’s dual action had no significant issues with edema or organ toxicity. Dive into the full #CME: . #Nephrology #KidneyCare

#ClinicianBurnout isn’t just about feeling tired—it’s unresolved stress, building quietly. #VitalNeuro uses real-time #EEG and neuro-responsive music to bring calm, focus and control on demand. Take a “Vital break” and hear how it works:

#Migraine in women can often mean later diagnosis, greater burden, and more missed care. At #WHAV2025, get the tools you need to: . - Improve diagnosis across life stages .- Use current treatment and prevention guidelines .- Personalize care with shared decision-making . NYC |

🧵5/5. Want to hear how #EEG tech could help clinicians fight burnout?. Check out this conversation on #NeuroFrontiers with Dr. Michael Greenberg and John Golden, all about how brain-based tools are changing the game: #PhysicianWellness #PhysicianBurnout.

🧵4/5. PROVIDERS: If you had a way to reset during your shift, when would you use it most?. #PhysicianWellness #PhysicianBurnout #Neurotechnology #VitalNeuro.